The number of analysts actively covering Albemarle (ALB) stock has increased from 19 to 20 over the previous month. Among the 20 analysts, 50.0% have recommended a “buy” for the stock, and another 50.0% have recommended a “hold.” None of the analysts have recommended a “sell” for the stock.
Analysts’ consensus indicates that Albemarle’s 12-month target price is $123.56, implying a potential return of 8.0% over the closing price of $114.46 as of August 29,2017.
Analysts are recommending a ‘hold’ or ‘buy’
ALB has posted two quarters of good earnings that beat analysts’ estimate. It has also maintained its guidance at $4.20–$4.40 per share for fiscal 2017. Positive developments such as a reduction in debt and a growing demand for lithium are expected to drive ALB’s future growth. All these factors could have influenced analysts to recommend a “buy” or a “hold” for the stock.
Individual brokerage recommendations
- Oppenheimer has rated Albemarle an “outperform” with a target price of $133, which implies a potential return of 16.2% over the closing price of $114.46 on August 29, 2017.
- Deutsche Bank (DB) has rated Albemarle a “buy” and has a target price of $128, implying a potential return of 11.3% over the closing price of $114.46 on August 29, 2017.
- Suntrust has downgraded Albemarle to a “hold” from a “buy” but did not provide a target price.
Investors can hold Albemarle indirectly by investing in the PowerShares WilderHill Progressive Energy ETF (PUW), which has invested 3.0% of its portfolio in ALB. The other holdings of the fund include FMC (FMC) and Owens Corning (OC) with weights of 3.1% and 2.9%, respectively, as of August 29, 2017.